Home / Products / Peptides / Retatrutide (10mg)
Retatrutide (10mg)
Third-party tested Retatrutide research peptide — triple GIP/GLP-1/glucagon agonist, ≥99.4% HPLC purity, CoA included. For laboratory research only.
Batch PL-RET-2601
Certificate of Analysis available
Product Overview
Retatrutide is a novel triple receptor agonist designed to activate GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors simultaneously. In preclinical and in-vitro metabolic research models, its combined receptor activity has made it a subject of intense scientific interest for studying energy expenditure, glucose homeostasis, and adipose tissue regulation. Prime Labs' Retatrutide peptide is synthesised via solid-phase peptide synthesis (SPPS) to ≥99.4% purity — verified by HPLC and high-resolution mass spectrometry. An independent, accredited third-party Certificate of Analysis (CoA) is batch-matched and included with every order. Supplied strictly for laboratory research — not for human or veterinary use.
Frequently Asked Questions
Specifications
- Purity
- ≥99.4% (HPLC verified)
- Molecular Form
- Lyophilized powder
- Storage
- -20°C, protect from light
- Vial Size
- 10mg
- Reconstitution
- Bacteriostatic water (research use)
- CoA
- Included with every batch
Lab Results
Batch PL-RET-2601 verified at 99.4% purity by independent laboratory testing.
Download Certificate of AnalysisFrequently Purchased Together
Customer Reviews
Based on 214 verified reviews
Exactly as specified on the CoA
Ran our own HPLC verification against the supplied CoA and the results matched within margin of error. Will reorder.
